ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,852.32
-1.39%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Mainz BioMed NV (MYNZ)

  7. Mainz BioMed NV (MYNZ) 뉴스

MYNZ Mainz BioMed NV

0.83
-0.0268 (-3.13%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Mainz BioMed NV MYNZ 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.0268 -3.13% 0.83 08:57:21
개장가 저가 고가 종가 전일 종가
0.8655 0.78 0.8794 0.8181 0.8568
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202422:29GLOBEMainz Biomed Reports Positive Topline Results from Pooled..
09/04/202421:01GLOBEMainz Biomed Reports Full Year 2023 Financial Results
19/03/202421:01GLOBEMainz Biomed Organizes HALLO DOC! Event to Highlight..
18/03/202421:01GLOBEMainz Biomed: Webinar on Early Detection of Colorectal..
12/03/202421:01GLOBEMainz Biomed Presents ColoAlert® at UDH Congress 2024:..
05/03/202422:01GLOBEMainz Biomed Partners with Trusted Health Advisors to..
27/02/202422:01GLOBEMainz Biomed to Showcase at the Gynecology Conference in..
22/02/202422:01GLOBEMainz Biomed Announces Distribution Partnership with..
21/02/202422:01GLOBEMainz Biomed Establishes Strategic Partnership with TomaLab..
06/02/202422:01GLOBEMainz Biomed Establishes Physician-Led Laboratory Expanding..
11/01/202422:01GLOBEMainz Biomed and TestDNA Drive CRC Innovation at the 10th..
09/01/202422:01GLOBEMainz Biomed Provides Year-End Corporate Review 2023
19/12/202322:01GLOBEMainz Biomed and Bantleon Partner to Elevate Corporate..
12/12/202322:01GLOBEMainz Biomed Showcases ColoAlert® at Two Prominent..
05/12/202323:01GLOBEMainz Biomed Reports Positive Topline Results from U.S...
29/11/202322:01GLOBEMainz Biomed’s Presentation at the 35th Annual Piper Sandler..
20/11/202322:01GLOBEMainz Biomed to Present at the 35th Annual Piper Sandler..
16/11/202322:01GLOBEMainz Biomed Reports Third Quarter 2023 Financial Results..
15/11/202323:01GLOBEMainz Biomed Announces Closing of $5.0 million Registered..
13/11/202323:00GLOBEMainz Biomed Announces Pricing of $5.0 million Registered..
09/11/202322:01GLOBEMainz Biomed Partners with Liquid Biosciences to Harness the..
07/11/202322:01GLOBEMainz Biomed to Showcase ColoAlert® at Leading Global..
31/10/202321:01GLOBEMainz Biomed Reports Success from Employee Colorectal Cancer..
26/10/202321:01GLOBEMainz Biomed Appoints Tarrin Khairi-Taraki as VP of..
18/10/202321:01GLOBEMainz Biomed Presents Groundbreaking Results of ColoFuture..
11/10/202321:01GLOBEMainz Biomed to Showcase ColoAlert® at UEG Week 2023 in..
05/10/202321:01GLOBEMainz Biomed to Attend the JonesTrading 2023 Healthcare..
04/10/202321:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
27/09/202321:01GLOBEMainz Biomed to Present Detailed Results of ColoFuture Study..
20/09/202316:01GLOBEMainz Biomed to Present at the Cantor Fitzgerald Global..
13/09/202316:01GLOBEMainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA..
05/09/202316:01GLOBEMainz Biomed Announces Strategic Partnership with Ärztliches..
29/08/202316:01GLOBEMainz Biomed to Present at the H.C. Wainwright Global..
22/08/202316:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
15/08/202319:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/08/202316:01GLOBEMainz Biomed Announces Financial Half Year Results 2023 and..
01/08/202316:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
18/07/202316:01GLOBEMainz Biomed Announces Collaboration with Fugene Genetics in..
12/07/202305:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/07/202305:15EDGAR2Form D - Notice of Exempt Offering of Securities
29/06/202316:01GLOBEMainz Biomed Secures up to $50M in New Funding
29/06/202305:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/06/202305:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/06/202316:01GLOBEMainz Biomed to Attend ESMO World Congress on..
20/06/202316:01GLOBEMainz Biomed Expands into Romania Through Partnership with..
31/05/202316:01GLOBEMainz Biomed Expands Commercial Footprint into Poland
24/05/202316:01GLOBEMainz Biomed Processes First Patients from Colorectal Cancer..
16/05/202316:01GLOBEMainz Biomed Announces First Quarter 2023 Financial Results..
10/05/202316:01GLOBEMainz Biomed Partners with Microba Life Sciences for the..
03/05/202316:01GLOBEMainz Biomed Announces Addition of Eurofins GeLaMed to its..

최근 히스토리

NASDAQ
MYNZ
Mainz BioMed NV
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유